LLMs in Healthcare: Accuracy Habits for Literature Reviews and Protocol Drafting

Introduction to LLMs in Healthcare R&D In the fast-evolving landscape of healthcare, large language models (LLMs) are transforming how organizations handle literature reviews and protocol drafting. For B2B leaders evaluating AI for operations, tools like LLMs promise to streamline AI drug discovery, clinical trial design, and biotech research. However, accuracy remains paramount—especially under regulatory scrutiny from FDA software as a medical device (SaMD) guidelines. As we approach 2026, platforms like the LUMOS multi-agent platform offer practical analysis of enterprise AI adoption, RAG (Retrieval-Augmented Generation), and agentic workflows. This article explores accuracy habits tailored for English-speaking B2B leaders, drawing on real-world applications in entities like Tempus and Insilico Medicine. The Role of LLMs in Literature Reviews Literature reviews form the backbone of AI

drug discovery and biotech innovation. Manually sifting through PubMed, clinical trial registries, and journals can take weeks. LLMs, integrated into clinical decision support AI, accelerate this by summarizing vast datasets. Key Benefits - Speed : Process thousands of papers in hours, identifying trends in AI medical imaging or LLM in healthcare applications. - Insight Extraction : Highlight gaps, such as underexplored HIPAA-compliant LLM integrations with EHRs like Epic or Cerner. - Scalability : Support prior authorization automation AI by reviewing reimbursement guidelines. Yet, without habits for accuracy, LLMs risk hallucinations—fabricating citations or misinterpreting data, as seen in early clinical documentation AI pilots. LLMs for Protocol Drafting: Opportunities and Pitfalls Clinical trial protocols demand precision. Sponsors use LLMs to draft sections on endpoints, inclusion

criteria, and safety monitoring, tying into how hospitals evaluate clinical AI assistants. Practical Applications - Biotech Efficiency : Insilico Medicine leverages similar AI for protocol design in drug discovery pipelines. - Risk Mitigation : Generate templates compliant with FDA SaMD AI requirements, reducing manual errors. - Customization : Tailor to specific therapies, like AI medical imaging protocols for oncology trials. Pitfalls include outdated knowledge (LLMs lack real-time access) and subtle biases, amplifying risks in patient-facing workflows. Accuracy Challenges in LLM-Driven Workflows LLMs excel at pattern matching but falter on novel or nuanced medical contexts. Common issues: - Hallucinations : Invented references during literature reviews. - Context Loss : Oversimplifying complex protocols, e.g., ignoring rare adverse events. - Regulatory Gaps : Non-compliance with HIPA

A pitfalls when connecting LLMs to EHRs. - Validation Shortfalls : Hospitals document model risk for clinical decision support tools, but AI-generated drafts often skip this. B2B leaders must address these to avoid "garbage in, garbage out" in operations. Essential Accuracy Habits for B2B Leaders Adopt these habits to harness LLMs responsibly, inspired by how clinical teams validate AI imaging claims from vendors. Habit 1: Implement Retrieval-Augmented Generation (RAG) RAG grounds LLMs in verified sources, reducing hallucinations by 50-70% in benchmarks. - Query trusted databases (PubMed, ClinicalTrials.gov). - Chunk and embed documents for precise retrieval. - LUMOS multi-agent platform excels here, orchestrating RAG for enterprise-scale literature reviews. Habit 2: Master Prompt Engineering Craft prompts like: "Summarize [paper] focusing on methodology, limitations, and relevance to [p

rotocol endpoint]. Cite verbatim." - Use chain-of-thought: "Step 1: Extract key findings..." - Role-play: "Act as a senior clinical researcher at Tempus." Habit 3: Deploy Multi-Agent Systems Single LLMs lack oversight; multi-agents simulate teams. - Agent Roles : Reviewer (checks facts), Drafter (generates), Validator (cross-references). - LUMOS Advantage : Provides practical analysis of RAG and agents, ideal for protocol design without skipping oversight. - Example: One agent scans for FDA SaMD alignment; another flags HIPAA risks. Habit 4: Human-in-the-Loop Validation Never deploy unvetted outputs. - Checklists : Verify citations, statistical claims, ethical considerations. - Peer Review : Mimic how sponsors use AI for protocol design—AI drafts, experts refine. - Metrics : Track factual accuracy via ROUGE scores or human eval. Habit 5: Guardrails and Auditing - Fine-Tuning : Use HIPAA-

compliant LLMs for sensitive data. - Logging : Audit trails for discharge summaries or patient education copy. - Testing : Simulate risks, like LLM-based scribes vs. rules-based systems. Real-World Examples and Case Studies - Tempus : Employs LLM in healthcare for oncology literature reviews, combin